Does EPLERENONE Cause Mobility decreased? 9 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Mobility decreased have been filed in association with EPLERENONE (Inspra). This represents 0.2% of all adverse event reports for EPLERENONE.
9
Reports of Mobility decreased with EPLERENONE
0.2%
of all EPLERENONE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Mobility decreased From EPLERENONE?
Of the 9 reports, 2 (22.2%) required hospitalization, and 2 (22.2%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPLERENONE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does EPLERENONE Cause?
Acute kidney injury (570)
Hypotension (398)
Dyspnoea (395)
Cardiac failure (338)
Oedema peripheral (268)
Dizziness (248)
Hyperkalaemia (248)
Drug ineffective (244)
Fatigue (202)
Off label use (188)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which EPLERENONE Alternatives Have Lower Mobility decreased Risk?
EPLERENONE vs EPLONTERSEN
EPLERENONE vs EPOETIN ALFA-EPBX
EPLERENONE vs EPOGEN
EPLERENONE vs EPOPROSTENOL
EPLERENONE vs EPTIFIBATIDE